15-85653928-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_007200.5(AKAP13):​c.4375-1489T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.752 in 152,076 control chromosomes in the GnomAD database, including 43,605 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.75 ( 43605 hom., cov: 31)

Consequence

AKAP13
NM_007200.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.391

Publications

3 publications found
Variant links:
Genes affected
AKAP13 (HGNC:371): (A-kinase anchoring protein 13) The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms containing c-terminal dbl oncogene homology (DH) and pleckstrin homology (PH) domains. The DH domain is associated with guanine nucleotide exchange activation for the Rho/Rac family of small GTP binding proteins, resulting in the conversion of the inactive GTPase to the active form capable of transducing signals. The PH domain has multiple functions. Therefore, these isoforms function as scaffolding proteins to coordinate a Rho signaling pathway, function as protein kinase A-anchoring proteins and, in addition, enhance ligand-dependent activity of estrogen receptors alpha and beta. [provided by RefSeq, Jul 2012]
AKAP13-AS1 (HGNC:55975): (AKAP13 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.04).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.883 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007200.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AKAP13
NM_007200.5
MANE Select
c.4375-1489T>C
intron
N/ANP_009131.2
AKAP13
NM_006738.6
c.4375-1489T>C
intron
N/ANP_006729.4
AKAP13
NM_001270546.1
c.295-1489T>C
intron
N/ANP_001257475.1B0AZU4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AKAP13
ENST00000394518.7
TSL:1 MANE Select
c.4375-1489T>C
intron
N/AENSP00000378026.3Q12802-1
AKAP13
ENST00000361243.6
TSL:1
c.4375-1489T>C
intron
N/AENSP00000354718.2Q12802-2
AKAP13
ENST00000560676.5
TSL:1
c.295-1489T>C
intron
N/AENSP00000481485.1A0A087WY36

Frequencies

GnomAD3 genomes
AF:
0.752
AC:
114269
AN:
151958
Hom.:
43550
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.890
Gnomad AMI
AF:
0.786
Gnomad AMR
AF:
0.701
Gnomad ASJ
AF:
0.814
Gnomad EAS
AF:
0.630
Gnomad SAS
AF:
0.579
Gnomad FIN
AF:
0.624
Gnomad MID
AF:
0.823
Gnomad NFE
AF:
0.717
Gnomad OTH
AF:
0.752
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.752
AC:
114385
AN:
152076
Hom.:
43605
Cov.:
31
AF XY:
0.744
AC XY:
55295
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.890
AC:
36932
AN:
41484
American (AMR)
AF:
0.702
AC:
10723
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.814
AC:
2822
AN:
3468
East Asian (EAS)
AF:
0.630
AC:
3246
AN:
5154
South Asian (SAS)
AF:
0.579
AC:
2793
AN:
4822
European-Finnish (FIN)
AF:
0.624
AC:
6585
AN:
10556
Middle Eastern (MID)
AF:
0.813
AC:
239
AN:
294
European-Non Finnish (NFE)
AF:
0.717
AC:
48748
AN:
67998
Other (OTH)
AF:
0.748
AC:
1580
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1403
2806
4209
5612
7015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.730
Hom.:
67001
Bravo
AF:
0.764
Asia WGS
AF:
0.630
AC:
2189
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.4
DANN
Benign
0.63
PhyloP100
-0.39
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs338538; hg19: chr15-86197159; API